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OBJECTIVE — The study’s objective was to assess the effects of automated telephone out-
reach with speech recognition (ATO-SR) on diabetes-related testing.
RESEARCH DESIGN AND METHODS — We identiﬁed 1,200 health plan members
who were overdue for diabetes-related testing and randomly allocated 600 to ATO-SR and 600
to usual care (no intervention). The intervention included three interactive calls encouraging
recommended testing. The primary outcome was retinopathy testing, since this was the health
plan’s principal goal. Tests for glycemia, hyperlipidemia, and nephropathy were secondary
outcomes.
RESULTS — In total, 232 participants (39%) verbally responded to the calls. There was no
difference between the intervention and the usual care groups in the primary outcome (adjusted
hazard ratio 0.93 [95% CI 0.71–1.22]) and no effect of the intervention on any of the secondary
outcomes.
CONCLUSIONS — Fewer than 40% of the patients randomized to ATO-SR interacted ver-
bally with the system. The intervention had no effect on the study’s outcomes.
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idely accepted guidelines deﬁne
effective strategies for the care of
patients with diabetes (1). How-
ever, many patients with diabetes do not
undergo recommended testing (2–5).
Two published randomized controlled
trials found that automated telephone
programs using live nurse follow-up im-
proved diabetes outcomes (6,7). The ob-
jective of this study was to assess the
effects of automated telephone outreach
with speech recognition (ATO-SR) on
rates of testing for retinopathy, glycemia,
hyperlipidemia, and nephropathy in a di-
verse population of privately insured pa-
tients with diabetes.
RESEARCH DESIGN AND
METHODS— This randomized con-
trolledtrialwasconductedatHarvardPil-
grim Health Care, a not-for-proﬁt health
plan. A ﬂow diagram of study participa-
tion is shown in supplementary Figure 1
(available in an online appendix at http://
care.diabetesjournals.org/cgi/content/full/
dc09-2332/DC1). In 2006, we identiﬁed
all 35,065 adult health plan members
with diabetes, 95% of whom had type 2
diabetes. We limited the sample to indi-
viduals with no insurance claim for a di-
lated eye examination in the prior year
and no claim for one or more of the fol-
lowingtests:A1C,LDLcholesterol,ormi-
croalbumin.From5,140eligiblepatients,
we randomly selected 1,200 individuals
andrandomlyallocatedthemtotheinter-
vention (n  600) and usual care (n 
600) groups.
We mailed a letter to all 600 patients
in the intervention group, informing
them that they would receive a series of
automated calls from Harvard Pilgrim to
support their diabetes care. We devel-
oped the intervention based on prior
studies (6–8). In particular, we con-
ductedaseriesofinterviewswithHarvard
Pilgrimpatientsandphysicianstocharac-
terize their willingness to interact with
ATO-SR and identiﬁed topics of interest
(8). The computerized system placed
three calls to the participants’ home tele-
phone numbers, encouraging the partici-
pants to fulﬁll recommended testing if it
had not been performed in the preceding
year. A summary of the call content is
shown in supplementary Table 1. The
computerized system used speech recog-
nitiontorespondtoparticipantswithseg-
ments of recorded text spoken with a
human voice. The automated system of-
fered a live telephone call back to assist in
scheduling tests and also offered to send
participants the following items: 1)a
voucher that would allow the provider to
waive the co-payment for a dilated eye
examination; 2) an educational nutrition
video; 3) a cookbook; or 4) a pill box. For
each of the three intervention calls, the
automated telephone system made up to
six attempts to reach the patient, leaving
uptotwomessagesrequestingacallback.
We used health plan membership
and claims records for all analyses. The
primary outcome measure was the com-
pletion of a dilated eye examination
among individuals without evidence of
examination in the preceding year. Sec-
ondary outcome measures were the com-
pletion of A1C, LDL cholesterol, and
microalbumin testing.
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Themainanalysesincludedallsubjectsin
the groups to which they were random-
ized. We used the Kaplan-Meier method
and log-rank test to assess the differences
between the intervention and usual care
groups in the time to the receipt of rec-
ommended testing and segmented pro-
portional hazards regression to account
for baseline differences in measured vari-
ables and for differential completion of
testing prior to the intervention.
RESULTS— Compared with the usual
care group, the intervention group was
younger (50 vs. 52 years, P  0.02) and
had a greater proportion of men (64 vs.
41%, P  0.04); the groups were compa-
rable on other socio-demographic mea-
sures and clinical indicators as shown in
supplementary Table 2. A total of 232
participants (39%) verbally responded to
the calls. The factors associated with call
participationareshowninsupplementary
Table 3.
In the primary analysis, there was no
differenceinthetimetothecompletionof
a dilated eye examination and no differ-
ence in the time to the completion of A1C
and microalbumin tests; the intervention
group had a shorter time to LDL choles-
terol testing (P  0.045 by the log-rank
test). The Kaplan-Meier curves are shown
in supplementary Fig. 2. In multivariate
analyses, there was no difference between
the intervention and usual care groups in
the time to a dilated eye examination (ad-
justed hazard ratio [HR] 0.93 [95% CI
0.71–1.22]) and no effect on times to the
secondary outcomes of A1C testing (0.72
[0.38–1.37]), LDL cholesterol testing
(1.31 [0.56–3.05]), and microalbumin
testing (1.14 [0.69–1.89]).
CONCLUSIONS — In this random-
ized controlled trial, only 39% of health
plan members randomized to the auto-
mated telephone outreach interacted ver-
bally with the system. The intervention
had no effect on the study’s outcomes.
Previous studies have shown modest
effects of automated telephone outreach
interventionstoimprovediabetescare,al-
though those interventions capitalized on
the involvement of a nurse or a diabetes
educator (6,7). To enhance the partici-
pants’ engagement, this study included
tokengifts,whichcouldreasonablybein-
cluded in a real-world intervention pro-
gram, but these gifts appeared to have no
effect on the outcome. The intervention
appeared to fail in part because a majority
of targeted patients did not meaningfully
interact with the system.
The study has several limitations.
First, the intervention was designed to
rely on automated systems rather than
human interactions. Targeted outreach
bycliniciansmayhaveyieldedhigherpar-
ticipation rates. Second, the high overall
rates of recommended testing in our
healthplanpopulationandthestudy’sfo-
cus on members who had not completed
testing in the prior year may have limited
effectiveness. This intervention might
have larger effects in other populations
with lower baseline testing rates. Third,
although we compared ATO-SR with
usual care, comparing this approach with
a telephone intervention using human
callerswouldalsobeuseful.Fourth,some
patients may have been told by their doc-
tors that they do not need to obtain an
annual eye exam. Because this was a ran-
domized trial, these patients were likely
distributedwithsimilarfrequencyinboth
study groups, making confounding
unlikely.
Automated telephone outreach may
be a valuable adjunct to programs for
improving diabetes care in large pop-
ulations. As with any technological inter-
vention, reﬁnement of this approach may
enhance its effectiveness; this “negative”
study does not rule out the potential for
future success. To be effective, these in-
terventions need to incorporate methods
for ensuring greater participation, possi-
bly through a partnership with clinicians.
Further research is also needed to under-
stand the characteristics of patients who
may resist this type of intervention in or-
dertodevelopalternativeapproachesthat
might be more effective.
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